NL-OMON29848尚未招募3 期
The H10 EORTC/GELA randomized Intergroup trial on early FDG-PET scan guided treatment adaption versus standard combined modality treatment in patiënts with supradiaphragmatic stage I/II Hodgkin's lymphoma - EORTC H10
European Organisation for Research in Treatment of Cancer (EORTC)0 个研究点目标入组 500 人开始时间: 待定最近更新:
试验速览
- 阶段
- 3 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 500
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Histologically confirmed Hodgkin's lymphoma (HL), except for nodular
- •lymphocyte predominant subtype (nodular paragranuloma)
- •Supradiaphragmatic Ann Arbor clinical stage I or II
- •Previously untreated
- •Clinical stages I/II
- •Age 15-70 years
- •WHO performance 0-3
- •FDG-PET scan prospectively planned after two cycles of ABVD in all
- •Informed consent
排除标准
- •No FDG-Pet scan facilities available
- •Inadequate liver-renal function (bili>2,5x uln or creat >2,5x uln
- •Unstable diabetes mellitus (because of FDG-PET scan
研究者
相似试验
进行中（未招募）
不适用
The H10 EORTC/GELA randomized Intergroup trial on early FDG-PET scan guided treatment adaptation versus standard combined modality treatment in patients with supradiaphragmatic stage I/II Hodgkin's lymphoma. - H10Hodgkin’s lymphomaMedDRA version: 8.1Level: HLGTClassification code 10025319Term: Lymphomas Hodgkin's diseaseEUCTR2005-002765-37-NLEuopean Organisation of Research and Treatment of Cancer1,600
进行中（未招募）
不适用
The H10 EORTC/GELA randomized Intergroup trial on early FDG-PET scan guided treatment adaptation versus standard combined modality treatment in patients with supradiaphragmatic stage I/II Hodgkin's lymphoma. - H10Supradiaphragmatic stage I/II Hodgkin’s lymphomaMedDRA version: 14.1Level: HLGTClassification code 10025319Term: Lymphomas Hodgkin's diseaseSystem Organ Class: 10005329 - Blood and lymphatic system disordersEUCTR2005-002765-37-BEEuopean Organisation of Research and Treatment of Cancer1,797
进行中（未招募）
不适用
The H10 EORTC/GELA randomized Intergroup trial on early FDG-PET scan guided treatment adaptation versus standard combined modality treatment in patients with supradiaphragmatic stage I/II Hodgkin's lymphoma. - H10Hodgkin’s lymphomaMedDRA version: 8.1Level: HLGTClassification code 10025319Term: Lymphomas Hodgkin's diseaseEUCTR2005-002765-37-DKEuopean Organisation of Research and Treatment of Cancer1,600
进行中（未招募）
1 期
The H10 EORTC/GELA randomized Intergroup trial on early FDG-PET scan guided treatment adaptation versus standard combined modality treatment in patients with supradiaphragmatic stage I/II Hodgkin's lymphoma. - H10Hodgkin’s lymphomaMedDRA version: 8.1 Level: HLGT Classification code 10025319 Term: Lymphomas Hodgkin's diseaseEUCTR2005-002765-37-SKEuopean Organisation of Research and Treatment of Cancer1,950
进行中（未招募）
不适用
The H10 EORTC/GELA randomized Intergroup trial on early FDGPET scan guided treatment adaptation versus standard combined modality treatment in patients with supradiaphragmatic stage I/II Hodgkin,s lymphomaPatients with supradiaphragmatic stage I/II Hodgkin`s lymphomaMedDRA version: 14.1Level: HLGTClassification code 10025319Term: Lymphomas Hodgkin's diseaseSystem Organ Class: 10005329 - Blood and lymphatic system disordersEUCTR2005-002765-37-ITEORTC Lymphoma Group1,797